Velasco-Guardado A et al. |
Potential protective effect of Helicobacter pylori on the development of gastrointestinal GvHD. |
2016 |
Bone Marrow Transplant. |
pmid:26950379
|
Mehta RS et al. |
Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation. |
2016 |
Br. J. Haematol. |
pmid:26947769
|
Kiyohara H et al. |
Up-to-date medical treatment for ulcerative colitis. |
2016 |
Nihon Shokakibyo Gakkai Zasshi |
pmid:26947041
|
Carcas-Sansuán AJ |
Limited sampling strategies for once daily tacrolimus exposure monitoring. |
2016 |
Eur. J. Clin. Pharmacol. |
pmid:26939899
|
Hazama Y et al. |
Effect of Physiological Changes in the Skin on Systemic Absorption of Tacrolimus Following Topical Application in Rats. |
2016 |
Biol. Pharm. Bull. |
pmid:26934927
|
Iguchi A et al. |
Graft-versus-host disease (GVHD) prophylaxis by using methotrexate decreases pre-engraftment syndrome and severe acute GVHD, and accelerates engraftment after cord blood transplantation. |
2016 |
Pediatr Transplant |
pmid:26526424
|
Kloster-Jensen K et al. |
Treatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by Adding Glucocorticoids. |
2016 |
J Diabetes Res |
pmid:26885529
|
Shen X et al. |
Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models. |
2016 |
Sci Rep |
pmid:27580845
|
Nakamura H et al. |
Usefulness of tacrolimus for refractory adult-onset still's disease: Report of six cases. |
2016 |
Mod Rheumatol |
pmid:25036233
|
Khan S et al. |
Tacrolimus-loaded nanostructured lipid carriers for oral delivery-in vivo bioavailability enhancement. |
2016 |
Eur J Pharm Biopharm |
pmid:27793753
|
Thölking G et al. |
Influence of tacrolimus metabolism rate on BKV infection after kidney transplantation. |
2016 |
Sci Rep |
pmid:27573493
|
Andrews LM et al. |
Consideration of the ethnic prevalence of genotypes in the clinical use of tacrolimus. |
2016 |
Pharmacogenomics |
pmid:27790923
|
Tang J et al. |
Cytokine Profile in Calcineurin Inhibitor-Induced Chronic Nephrotoxicity in Chinese Liver Transplant Recipients. |
2016 |
Transplant. Proc. |
pmid:27788813
|
Fukuta T et al. |
Non-invasive evaluation of neuroprotective drug candidates for cerebral infarction by PET imaging of mitochondrial complex-I activity. |
2016 |
Sci Rep |
pmid:27440054
|
Dugast E et al. |
Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients. |
2016 |
Am. J. Transplant. |
pmid:27367750
|
Högerle BA et al. |
Challenging immunosuppression treatment in lung transplant recipients with kidney failure. |
2016 |
Transpl. Immunol. |
pmid:26892232
|
Kolb M et al. |
Risk Factors for Subtherapeutic Tacrolimus Levels after Conversion from Continuous Intravenous Infusion to Oral in Children after Allogeneic Hematopoietic Cell Transplantation. |
2016 |
Biol. Blood Marrow Transplant. |
pmid:26880117
|
Arreola-Guerra JM et al. |
Tacrolimus Trough Levels as a Risk Factor for Acute Rejection in Renal Transplant Patients. |
2016 |
Ann. Transplant. |
pmid:26879833
|
Kimura H et al. |
Has widespread use of biologic and immunosuppressant therapy for ulcerative colitis affected surgical trends? Results of a questionnaire survey of surgical institutions in Japan. |
2016 |
Surg. Today |
pmid:26467558
|
Žilinská Z et al. |
Impact of Trough Levels of Tacrolimus on Kidney Function and Graft Survival in Short and Longer Periods After Renal Transplantation. |
2016 |
Transplant. Proc. |
pmid:27788794
|
Brooks E et al. |
Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet? |
2016 |
Clin Pharmacokinet |
pmid:27138787
|
Rebora A |
Tacrolimus and oral lichen planus. Possible absorption after mucosal application? |
2016 |
J Eur Acad Dermatol Venereol |
pmid:26372839
|
Dharnidharka VR et al. |
Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study. |
2016 |
Transpl. Int. |
pmid:27564782
|
Ohe M et al. |
A case of lupus nephritis treated with clarithromycin, tacrolimus, and glucocorticoids. |
2016 |
Kaohsiung J. Med. Sci. |
pmid:27638410
|
Rostaing L et al. |
Successful Transplantation in ABO- and HLA-Incompatible Living Kidney Transplant Patients: A Report on 12 Cases. |
2016 |
Ther Apher Dial |
pmid:27073167
|
Wang N et al. |
Paclitaxel and Tacrolimus Coencapsulated Polymeric Micelles That Enhance the Therapeutic Effect of Drug-Resistant Ovarian Cancer. |
2016 |
ACS Appl Mater Interfaces |
pmid:26809267
|
Pirojsakul K et al. |
Management of sensitized pediatric patients prior to renal transplantation. |
2016 |
Pediatr. Nephrol. |
pmid:26801944
|
Guo YW et al. |
Successful treatment of ileal ulcers caused by immunosuppressants in two organ transplant recipients. |
2016 |
World J. Gastroenterol. |
pmid:27350740
|
Gabriel D et al. |
Improved topical delivery of tacrolimus: A novel composite hydrogel formulation for the treatment of psoriasis. |
2016 |
J Control Release |
pmid:27639683
|
Vasu S et al. |
Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease. |
2016 |
Biol. Blood Marrow Transplant. |
pmid:26743340
|
Yoo EC et al. |
Developmental changes of MPA exposure in children. |
2016 |
Pediatr. Nephrol. |
pmid:26743220
|
Yingfang F et al. |
Pimecrolimus micelle exhibits excellent therapeutic effect for Keratoconjunctivitis Sicca. |
2016 |
Colloids Surf B Biointerfaces |
pmid:26731192
|
Nekkanti V et al. |
Design, Characterization, and In Vivo Pharmacokinetics of Tacrolimus Proliposomes. |
2016 |
AAPS PharmSciTech |
pmid:26729532
|
Armand P et al. |
The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial. |
2016 |
Br. J. Haematol. |
pmid:26729448
|
Sommerer C et al. |
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:26888217
|
Choi WJ et al. |
Oral administration of Lactococcus chungangensis inhibits 2,4-dinitrochlorobenzene-induced atopic-like dermatitis in NC/Nga mice. |
2016 |
J. Dairy Sci. |
pmid:27289147
|
Haasova M et al. |
Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation. |
2016 |
Health Technol Assess |
pmid:27557331
|
Bapur Erduran F and Adışen E |
Comparison of the efficacy of 308-nm excimer lamp monotherapy with topical tacrolimus or clobetasol 17-propionate combination therapies in localized vitiligo. |
2016 |
Photodermatol Photoimmunol Photomed |
pmid:27552312
|
Badr R et al. |
Assessment of global ischemic/reperfusion and Tacrolimus administration on CA1 region of hippocampus: gene expression profiles of BAX and BCL2 genes. |
2016 |
Bratisl Lek Listy |
pmid:27546370
|
Tsuji T et al. |
Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC/Nga mice. |
2016 |
Allergol Int |
pmid:26666476
|
Hanaoka K et al. |
A chronic renal rejection model with a fully MHC-mismatched rat strain combination under immunosuppressive therapy. |
2016 |
Transpl. Immunol. |
pmid:27545900
|
Speckmann T et al. |
Npas4 Transcription Factor Expression Is Regulated by Calcium Signaling Pathways and Prevents Tacrolimus-induced Cytotoxicity in Pancreatic Beta Cells. |
2016 |
J. Biol. Chem. |
pmid:26663079
|
Fang YP et al. |
What is the discrepancy between drug permeation into/across intact and diseased skins? Atopic dermatitis as a model. |
2016 |
Int J Pharm |
pmid:26657274
|
Thao le Q et al. |
Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues. |
2016 |
Int J Pharm |
pmid:26657273
|
Mokuda S and Oiwa H |
Successful treatment of FKBP51-expressed multicentric reticulohistiocytosis using combination therapy with low-dose denosumab and tacrolimus. |
2016 |
Scand. J. Rheumatol. |
pmid:26652057
|
Ren H et al. |
Phosphatase inhibition increases AQP2 accumulation in the rat IMCD apical plasma membrane. |
2016 |
Am. J. Physiol. Renal Physiol. |
pmid:27488997
|
Albeiroti S et al. |
Evaluation of 2 Batched Pretreatment Systems for the Measurement of Whole Blood Tacrolimus on the ARCHITECT Immunoassay Analyzer. |
2016 |
Lab Med |
pmid:27474776
|
Yu H et al. |
Risk factors for new-onset diabetes mellitus after living donor kidney transplantation in Korea - a retrospective single center study. |
2016 |
BMC Nephrol |
pmid:27473469
|
Woolner K and Sauder M |
Periorbital erythema following alcohol ingestion during treatment with topical tacrolimus. |
2016 |
CMAJ |
pmid:26598374
|
Park JS et al. |
A rapid and sensitive method to determine tacrolimus in rat whole blood using liquid-liquid extraction with mild temperature ultrasonication and LC-MS/MS. |
2016 |
Arch. Pharm. Res. |
pmid:26589688
|
Filler G et al. |
Minimum mycophenolic acid levels are associated with donor-specific antibody formation. |
2016 |
Pediatr Transplant |
pmid:26589470
|
Scalea JR et al. |
Tacrolimus for the prevention and treatment of rejection of solid organ transplants. |
2016 |
Expert Rev Clin Immunol |
pmid:26588770
|
Dabrowska-Zamojcin E et al. |
CCL2 gene polymorphism is associated with post-transplant diabetes mellitus. |
2016 |
Int. Immunopharmacol. |
pmid:26802601
|
Sakai R et al. |
A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey. |
2016 |
Int. J. Hematol. |
pmid:26800676
|
Pouché L et al. |
New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugs. |
2016 |
Pharmacogenomics |
pmid:26799749
|
Yoshida S et al. |
Treatment with DHA/EPA ameliorates atopic dermatitis-like skin disease by blocking LTB4 production. |
2016 |
J. Med. Invest. |
pmid:27644556
|
Tanriover B et al. |
Acute Rejection Rates and Graft Outcomes According to Induction Regimen among Recipients of Kidneys from Deceased Donors Treated with Tacrolimus and Mycophenolate. |
2016 |
Clin J Am Soc Nephrol |
pmid:27364616
|
Ordóñez-Robles M et al. |
Target genes of the Streptomyces tsukubaensis FkbN regulator include most of the tacrolimus biosynthesis genes, a phosphopantetheinyl transferase and other PKS genes. |
2016 |
Appl. Microbiol. Biotechnol. |
pmid:27357227
|
Wu SY et al. |
Comprehensive risk assessment for early neurologic complications after liver transplantation. |
2016 |
World J. Gastroenterol. |
pmid:27350733
|
Constantinescu AA et al. |
Differential influence of tacrolimus and sirolimus on mitochondrial-dependent signaling for apoptosis in pancreatic cells. |
2016 |
Mol. Cell. Biochem. |
pmid:27344165
|
Shao K et al. |
Different Effects of Tacrolimus on Innate and Adaptive Immune Cells in the Allograft Transplantation. |
2016 |
Scand. J. Immunol. |
pmid:26524694
|
Cena T et al. |
De novo noncutaneous malignancies after kidney transplantation are associated with an increased risk of graft failure: results from a time-dependent analysis on 672 patients. |
2016 |
Transpl. Int. |
pmid:27343849
|
Handisurya A et al. |
Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients. |
2016 |
PLoS ONE |
pmid:26735686
|
Binkhathlan Z et al. |
Reutilization of Tacrolimus Extracted from Expired Prograf® Capsules: Physical, Chemical, and Pharmacological Assessment. |
2016 |
AAPS PharmSciTech |
pmid:26729529
|
Chacon A and Mercer J |
Successful management of angiolymphoid hyperplasia with eosinophilia in a split-face trial of topical tacrolimus and timolol solution. |
2016 |
G Ital Dermatol Venereol |
pmid:25014586
|
Tsuji H et al. |
Efficacy and Safety of Grapefruit Juice Intake Accompanying Tacrolimus Treatment in Connective Tissue Disease Patients. |
2016 |
Intern. Med. |
pmid:27301503
|
Pizzo HP et al. |
Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence. |
2016 |
Pediatr. Nephrol. |
pmid:27286686
|
Fernández de Castillo Torras L et al. |
Treatment with ulipristal acetate (Esmya(®)) and plasma levels of tacrolimus: a case report. |
2016 |
Eur. J. Obstet. Gynecol. Reprod. Biol. |
pmid:27282803
|
Youssef M et al. |
Asymptomatic papulonodular lesions in zosteriform distribution in an immunocompromised patient. |
2016 |
Int. J. Dermatol. |
pmid:26463835
|
Ferjani H et al. |
The evaluate and compare the effects of the Tacrolimus and Sirolimus on the intestinal system using an intestinal cell culture model. |
2016 |
Toxicol. Mech. Methods |
pmid:26460985
|
Sharma A et al. |
Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants. |
2016 |
Prog Transplant |
pmid:27207404
|
Menninga NJ et al. |
Restless Legs Syndrome Following Lung Transplantation: Prevalence and Relationship With Tacrolimus Exposure. |
2016 |
Prog Transplant |
pmid:27207403
|
Jebabli N et al. |
Consequences of erroneous phone transmission of tacrolimus blood concentration: A case report. |
2016 |
Therapie |
pmid:27203160
|
Sasaki T et al. |
Characteristic features of tacrolimus-induced lung disease in rheumatoid arthritis patients. |
2016 |
Clin. Rheumatol. |
pmid:25644583
|
Reeves TM et al. |
Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury. |
2016 |
Exp. Neurol. |
pmid:27302680
|
Nerattini F et al. |
II. Dissociation free energies in drug-receptor systems via nonequilibrium alchemical simulations: application to the FK506-related immunophilin ligands. |
2016 |
Phys Chem Chem Phys |
pmid:27193181
|
O'Regan JA et al. |
Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation. |
2016 |
J. Nephrol. |
pmid:26374111
|
Seok J et al. |
Recalcitrant steroid-induced rosacea successfully treated with 0.03% tacrolimus and 595-nm pulsed dye laser. |
2016 |
Eur J Dermatol |
pmid:27193042
|
Caillard S et al. |
Advagraf(®) , a once-daily prolonged release tacrolimus formulation, in kidney transplantation: literature review and guidelines from a panel of experts. |
2016 |
Transpl. Int. |
pmid:26373896
|
Matsukawa T et al. |
Reduced-dose methotrexate in combination with tacrolimus was associated with rapid engraftment and recovery from oral mucositis without affecting the incidence of GVHD. |
2016 |
Int. J. Hematol. |
pmid:27119977
|
Alvarez-ElÃas AC et al. |
CYP3A5 Genotype and Time to Reach Tacrolimus Therapeutic Levels in Renal Transplant Children. |
2016 |
Transplant. Proc. |
pmid:27110018
|
Reiner J et al. |
After Intestinal Transplantation Kidney Function Is Impaired by Downregulation of Epithelial Ion Transporters in the Ileum. |
2016 |
Transplant. Proc. |
pmid:27109987
|
Peng L et al. |
Comparison of different therapies in high-risk patients with idiopathic membranous nephropathy. |
2016 |
J. Formos. Med. Assoc. |
pmid:26315481
|
Rao B et al. |
Use of Everolimus After Multivisceral Transplantation: A Report of Two Cases. |
2016 |
Transplant. Proc. |
pmid:27109983
|
Chang HK et al. |
Ten-Year Experience With Bowel Transplantation at Seoul St. Mary's Hospital. |
2016 |
Transplant. Proc. |
pmid:27109981
|
Ruangkanchanasetr P et al. |
Beta Cell Function and Insulin Resistance After Conversion from Tacrolimus Twice-Daily to Extended-Release Tacrolimus Once-Daily in Stable Renal Transplant Recipients. |
2016 |
Ann. Transplant. |
pmid:27980321
|
Castagna L et al. |
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide. |
2016 |
Bone Marrow Transplant. |
pmid:26595078
|
Kishida N et al. |
Increased Incidence of Thrombotic Microangiopathy After ABO-Incompatible Living Donor Liver Transplantation. |
2016 |
Ann. Transplant. |
pmid:27956735
|
Yamamoto T et al. |
Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis--authors' reply. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27040167
|
Taylor KM and Sparrow MP |
Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27040166
|
Imamura CK et al. |
Impact of cytochrome P450 2C19 polymorphisms on the pharmacokinetics of tacrolimus when coadministered with voriconazole. |
2016 |
J Clin Pharmacol |
pmid:26239045
|
Lonowski S et al. |
Vitiligo: a potential autoimmune sequela of DRESS syndrome. |
2016 |
Br. J. Dermatol. |
pmid:27038429
|
Wang Y et al. |
Preparation, characterization and in vivo evaluation of amorphous tacrolimus nanosuspensions produced using CO2-assisted in situ nanoamorphization method. |
2016 |
Int J Pharm |
pmid:27034003
|
Jimbo H et al. |
Telangiectatic lichen sclerosus on the cheek successfully treated with topical tacrolimus. |
2016 |
Eur J Dermatol |
pmid:27033557
|
Shimizu K et al. |
Specific delivery of an immunosuppressive drug to splenic B cells by antigen-modified liposomes and its antiallergic effect. |
2016 |
J Drug Target |
pmid:27030163
|
Yan Y et al. |
Robust Axonal Regeneration in a Mouse Vascularized Composite Allotransplant Model Undergoing Delayed Tissue Rejection. |
2016 |
Hand (N Y) |
pmid:28149214
|
GarcÃa-Bello JA et al. |
Effect of Immunosuppressive Therapy on Cardiovascular Risk Factor Prevalence in Kidney-Transplanted Children: Comparative Study. |
2016 |
Transplant. Proc. |
pmid:27110020
|
Gu C et al. |
Triptolide Reduces the Required Dose of Tacrolimus by Attenuating Inflammation, Enhancing Immunosuppression, and Increasing Donor Chimerism in a Heterotopic Hindlimb Transplantation Model. |
2016 |
Plast. Reconstr. Surg. |
pmid:27879593
|
Carrillo-Ibarra S et al. |
The Oxidative and Inflammatory State in Patients with Acute Renal Graft Dysfunction Treated with Tacrolimus. |
2016 |
Oxid Med Cell Longev |
pmid:27872679
|
Thomusch O et al. |
Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial. |
2016 |
Lancet |
pmid:27871759
|